Posted on 11/12/2021 9:07:12 AM PST by Grandpa Drudge
Abstract
SARS-CoV in 2003, SARS-CoV-2 in 2019, and SARS-CoV-2 variants of concern (VOC) can cause deadly infections, underlining the importance of developing broadly effective countermeasures against Group 2B Sarbecoviruses, which could be key in the rapid prevention and mitigation of future zoonotic events. Here, we demonstrate the neutralization of SARS-CoV, bat CoVs WIV-1 and RsSHC014, and SARS-CoV-2 variants D614G, B.1.1.7, B.1.429, B1.351 by a receptor-binding domain (RBD)-specific antibody DH1047. Prophylactic and therapeutic treatment with DH1047 demonstrated protection against SARS-CoV, WIV-1, RsSHC014, and SARS-CoV-2 B1.351infection in mice. Binding and structural analysis showed high affinity binding of DH1047 to an epitope that is highly conserved among Sarbecoviruses. We conclude that DH1047 is a broadly neutralizing and protective antibody that can prevent infection and mitigate outbreaks caused by SARS-like strains and SARS-CoV-2 variants. Our results argue that the RBD conserved epitope bound by DH1047 is a rational target for pan Group 2B coronavirus vaccines.
(Excerpt) Read more at ncbi.nlm.nih.gov ...
I hope it's really real...
Only because you aren't making money from the sales )and kickbacks) that go away when the EUA is voided by an effective treatment...
**
https://freerepublic.com/focus/f-bloggers/4012177/posts
Isn’t it amazing that HCQ, Ivermectin, and Pfizer’s PAXLOVID ($72per pill) all inhibit the same SARS 3CLpro enzyme to inhibit replication? twitter ^ | Nov 11th, 2021 | Clarke MD
Posted on 11/12/2021, 11:09:51 AM by Mount Athos
Weird that two are “snake oil” and the expensive one will get EUA {Emergency Use Authorization by the FDA}
new tagline
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.